Perrigo Company plc (NYSE:PRGO - Get Free Report) saw unusually large options trading activity on Friday. Stock investors purchased 11,734 call options on the stock. This represents an increase of approximately 637% compared to the typical daily volume of 1,593 call options.
Analyst Ratings Changes
PRGO has been the topic of a number of research reports. Argus downgraded shares of Perrigo from a "buy" rating to a "hold" rating in a report on Tuesday, January 14th. Piper Sandler cut shares of Perrigo from an "overweight" rating to a "neutral" rating and reduced their target price for the company from $34.00 to $27.00 in a report on Monday, January 6th. Finally, StockNews.com cut shares of Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Perrigo currently has a consensus rating of "Hold" and an average target price of $33.00.
Check Out Our Latest Report on Perrigo
Perrigo Stock Performance
NYSE PRGO traded up $0.37 on Tuesday, hitting $29.37. 3,048,132 shares of the company traded hands, compared to its average volume of 1,479,157. The business's 50 day moving average price is $25.08 and its 200-day moving average price is $26.21. The company has a market capitalization of $4.01 billion, a price-to-earnings ratio of -25.10 and a beta of 0.54. Perrigo has a 52-week low of $23.14 and a 52-week high of $33.46. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94.
Perrigo (NYSE:PRGO - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.01. The company had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.20 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. Equities analysts expect that Perrigo will post 2.56 earnings per share for the current year.
Perrigo Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Friday, March 7th will be paid a dividend of $0.29 per share. This is a boost from Perrigo's previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 7th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 3.95%. Perrigo's payout ratio is -92.80%.
Insider Buying and Selling
In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the firm's stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $28.27, for a total value of $497,495.46. Following the transaction, the director now directly owns 5,409 shares of the company's stock, valued at approximately $152,912.43. This trade represents a 76.49 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.70% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Perrigo during the fourth quarter worth about $383,000. University of Texas Texas AM Investment Management Co. grew its position in shares of Perrigo by 12.0% during the fourth quarter. University of Texas Texas AM Investment Management Co. now owns 38,424 shares of the company's stock worth $988,000 after purchasing an additional 4,105 shares in the last quarter. Novem Group purchased a new position in shares of Perrigo in the fourth quarter worth $2,601,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Perrigo by 14.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 480,961 shares of the company's stock worth $12,366,000 after buying an additional 61,824 shares in the last quarter. Finally, iSAM Funds UK Ltd purchased a new position in shares of Perrigo in the fourth quarter worth $242,000. Hedge funds and other institutional investors own 95.91% of the company's stock.
About Perrigo
(
Get Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Read More
Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.